How do you pay?

How to pay the least

Cash price

$3,270+ for 30 tablets

Pharmacies pay about this for Ubrelvy; you’d pay more.

  1. Ask your pharmacy for Ubrelvy’s cash price, and one or two other pharmacies too.
  2. Ubrelvy’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify myAbbVie Assist. Our income guidelines are based on the size of your household and annual income. Or call 1-800-222-6885.

See if you qualify 

No generic is sold yet.

Compare every option

Question
Brand nameUbrelvy
Authorized genericubrogepant
Regular genericubrogepant
What you’d pay
At least$3,270for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Ubrelvy?
The original
–
–

Brand nameThe maker’s card

UBRELVY Complete Savings Card

Savings card from AbbVie (Allergan)

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

The card takes up to $7,000 a year off your co-pay.

Sign up on ubrelvy.com 

Or call 1-844-577-6239.

In the maker’s words

“Eligible commercially insured patients may pay as little as $0 per monthly prescription fill.”

From the maker’s offer on ubrelvy.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Ubrelvy itself, from the same company, sold without the brand name, and usually for less. For now Ubrelvy is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

UBRELVY is a calcitonin gene-related peptide receptor antagonist indicated for the acute treatment of migraine with or without aura in adults.

Limitations of Use

UBRELVY is not indicated for the preventive treatment of migraine.

Source: the FDA label for Ubrelvy (Allergan, Inc.), June 5, 2025. Full label on DailyMed 

Good to know